Dicerna Pharmaceuticals: Q3 Earnings Insights

 

Dicerna Pharmaceuticals DRNA reported its Q3 earnings results on Tuesday, November 9, 2021 at 08:00 AM.

Here's what investors need to know about the announcement.

Earnings

Dicerna Pharmaceuticals their estimated earnings by 52.17%, reporting an EPS of $-0.22 versus an estimate of $-0.46, which surprised analysts.

Revenue was up $14,079,000 from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.94, which was followed by a 6.88% drop in the share price the next day.

Here's a look at Dicerna Pharmaceuticals's past performance:

 

Quarter Q2 2021 Q1 2021 Q4 2020 Q3 2020
EPS Estimate 0.41 -0.37 -0.03 -0.20
EPS Actual -0.53 -0.39 -0.49 -0.29
Revenue Estimate 91.29M 46.28M 67.25M 51.50M
Revenue Actual 41.34M 47.60M 40.96M 48.88M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: EarningsNewsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!